Prosecution Insights
Last updated: August 06, 2026

National Cancer Center

8 pending office actions • 5 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (62%)
3
Medium (38%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (38%)
§103 only1 (12%)
§102 only2 (25%)
Multi-statute (no §101)2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
38% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
38% of docket
2
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PATEL, DHAVAL V 2 85.9% +14.9%
MONAHAN, MEGAN ELIZABETH 1 57.9% +15.9%
EKRAMI, YASAMIN 1 41.8% +47.1%
ABBASI, ABDUL HADI 1 0.0% +0.0%
OGUNTADE, ELIZABETH BISOLA 1 0.0% +0.0%
ARMATO JR, DENNIS IGNATIUS 1 47.4% +76.9%
BELYAVSKYI, MICHAIL A 1 64.1% +27.7%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 84d
18789060 INFORMATION PROCESSING APPARATUS, CONTROL METHOD, AND NON-TRANSITORY STORAGE MEDIUM PATEL, DHAVAL V
18789129 INFORMATION PROCESSING APPARATUS, CONTROL METHOD, AND NON-TRANSITORY STORAGE MEDIUM PATEL, DHAVAL V
18777636 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM ABBASI, ABDUL HADI
18283274 METHOD AND KIT FOR ASSISTING IN DETERMINATION OF MALIGNANT PANCREATIC CYSTIC TUMOR OGUNTADE, ELIZABETH BISOLA

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 84d
18897470 ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM MONAHAN, MEGAN ELIZABETH
18839816 HAIR LOSS PREVENTING DEVICE FOR ANTICANCER TREATMENT EKRAMI, YASAMIN
18789060 INFORMATION PROCESSING APPARATUS, CONTROL METHOD, AND NON-TRANSITORY STORAGE MEDIUM PATEL, DHAVAL V
18789129 INFORMATION PROCESSING APPARATUS, CONTROL METHOD, AND NON-TRANSITORY STORAGE MEDIUM PATEL, DHAVAL V
17904926 METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS BELYAVSKYI, MICHAIL A

Top Art Units

Art UnitApps
3795 2
3794 1
1677 1
1651 1
1644 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18897470 ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM MONAHAN, MEGAN ELIZABETH 3795 §102 Non-Final OA Pending Sep 26, 2024
18839816 HAIR LOSS PREVENTING DEVICE FOR ANTICANCER TREATMENT EKRAMI, YASAMIN 3794 §103 Non-Final OA Pending Aug 20, 2024
18789060 INFORMATION PROCESSING APPARATUS, CONTROL METHOD, AND NON-TRANSITORY STORAGE MEDIUM PATEL, DHAVAL V §101§103Other Non-Final OA Pending Jul 30, 2024
18789129 INFORMATION PROCESSING APPARATUS, CONTROL METHOD, AND NON-TRANSITORY STORAGE MEDIUM PATEL, DHAVAL V §101§102Other Non-Final OA Pending Jul 30, 2024
18777636 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM ABBASI, ABDUL HADI 3795 §102§103 Non-Final OA Pending Jul 19, 2024
18283274 METHOD AND KIT FOR ASSISTING IN DETERMINATION OF MALIGNANT PANCREATIC CYSTIC TUMOR OGUNTADE, ELIZABETH BISOLA 1677 §101§103§112Other Non-Final OA Pending Sep 21, 2023
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 1651 §102§103 Final Rejection 84d Pending Apr 27, 2023
17904926 METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS BELYAVSKYI, MICHAIL A 1644 §102 Final Rejection Pending Aug 24, 2022

Managing National Cancer Center's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month